Literature DB >> 8392322

Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

S Tanaka1, Y Toh, R Mori.   

Abstract

Thymidine kinase (TK) of herpes simplex virus (HSV) has been identified as one of the factors responsible for its virulence. We have previously isolated acyclovir (ACV)-resistant HSV type 2 (HSV-2), strain YS-4 C-1, by simple plaque cloning from a clinical isolate. Although YS-4 C-1 had extremely low TK activity, it retained high virulence in mice. To determine the mechanism of the reduction of TK activity, a molecular analysis of the YS-4 C-1 TK gene was performed. YS-4 C-1 produced TK mRNA, which was indistinguishable both in size and amount from that of wild-type strains. However, the YS-4 C-1 TK had a single amino acid change from serine to asparagine at amino acid residue 182 of the TK polypeptide, which was caused by a single nucleotide mutation. It was situated within a highly conserved region (162-194) and close to the putative nucleoside-binding site (169-177), one of the three active centers of TK. In order to confirm the effect of this missense mutation on both the TK activity and neurovirulence, the mutation was introduced into the TK genes of wild-type strains. Although all the recombinants were altered to ACV-resistant viruses with reduced TK activity, they retained high neurovirulence for mice. Our study thus suggested that this mutant TK, in spite of low activity, might play a role in the neurovirulence of HSV-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392322     DOI: 10.1007/bf01379080

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

Review 2.  Significance of resistance of herpes simplex virus to acyclovir.

Authors:  C S Crumpacker
Journal:  J Am Acad Dermatol       Date:  1988-01       Impact factor: 11.527

3.  Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide.

Authors:  D Graham; B A Larder; M M Inglis
Journal:  J Gen Virol       Date:  1986-04       Impact factor: 3.891

4.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

5.  Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.

Authors:  G Darby; H J Field; S A Salisbury
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

6.  The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups.

Authors:  K Yoshioka; T Miki; T Katsuya; T Ogihara; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

Review 7.  Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency.

Authors:  R B Tenser
Journal:  Intervirology       Date:  1991       Impact factor: 1.763

8.  Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.

Authors:  H J Field; E Lay
Journal:  Antiviral Res       Date:  1984-04       Impact factor: 5.970

9.  Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.

Authors:  A D Idowu; E B Fraser-Smith; K L Poffenberger; R C Herman
Journal:  Antiviral Res       Date:  1992-02       Impact factor: 5.970

10.  Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.

Authors:  F Nugier; J N Colin; M Aymard; M Langlois
Journal:  J Med Virol       Date:  1992-01       Impact factor: 2.327

View more
  4 in total

Review 1.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.

Authors:  T Suzutani; M Saijo; M Nagamine; M Ogasawara; M Azuma
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Authors:  Deborah Watson-Jones; Anna Wald; Connie Celum; Jairam Lingappa; Helen A Weiss; John Changalucha; Kathy Baisley; Clare Tanton; Richard J Hayes; Joshua O Marshak; Rula Green Gladden; David M Koelle
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

4.  Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.

Authors:  J J Sasadeusz; F Tufaro; S Safrin; K Schubert; M M Hubinette; P K Cheung; S L Sacks
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.